Adamas Operations Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ADAMAS OPERATIONS, and when can generic versions of ADAMAS OPERATIONS drugs launch?
ADAMAS OPERATIONS has two approved drugs.
There are thirty US patents protecting ADAMAS OPERATIONS drugs.
There are forty-five patent family members on ADAMAS OPERATIONS drugs in eleven countries.
Summary for Adamas Operations
International Patents: | 45 |
US Patents: | 30 |
Tradenames: | 2 |
Ingredients: | 1 |
NDAs: | 2 |
Drugs and US Patents for Adamas Operations
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adamas Operations | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-002 | Aug 24, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Adamas Operations | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-001 | Aug 24, 2017 | RX | Yes | No | 8,895,617 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-002 | Feb 16, 2018 | RX | Yes | No | 10,512,617 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-003 | Feb 16, 2018 | DISCN | Yes | No | 8,252,331 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Adamas Operations
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-001 | Feb 16, 2018 | RE39069 | ⤷ Try a Trial |
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-003 | Feb 16, 2018 | RE39069 | ⤷ Try a Trial |
Adamas Operations | OSMOLEX ER | amantadine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 209410-002 | Feb 16, 2018 | RE39069 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Adamas Operations Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2018100306 | ⤷ Try a Trial |
Japan | 5325421 | ⤷ Try a Trial |
Mexico | 2020002078 | ⤷ Try a Trial |
Mexico | 2007006472 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.